Advertisement

Topics

The Institutes for Pharmaceutical Discovery, LLC Company Profile

00:38 EST 22nd November 2017 | BioPortfolio

The Institutes for Pharmaceutical Discovery, LLC (IPD) is a privately held company founded by James M. Nolan, President and CEO, and Gordon Polley, Chairman.IPD is managed by a cadre of experienced pharmaceutical executives, financial managers and dedicated senior scientists, all of whom have had extensive experience in pharmaceutical drug development. This group also oversees the vision and function of each individual institute it creates...

Location

23 Business Park Drive
Branford
Connecticut
06405
United States of America

Contact

Email: info@ipd-discovery.com


News Articles [1039 Associated News Articles listed on BioPortfolio]

Daiichi Sankyo announces TaNeDS Global 2018 collaborative drug discovery program

Daiichi Sankyo Company, Limited today announced details of the application for its Take a New Challenge for Drug Discovery (TaNeDS) Global 2018, a collaborative drug discovery initiative for universit...

Drug Discovery Outsourcing Global Market Forecast To 2022 [Report Updated: 13012016] Prices from USD $15000

Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift to...

Discovery Zone

Last spring, veteran pharmaceutical executive and entrepreneur Dr. William Polvino was tapped as CEO of Bridge Medicines, a company established in October 2016 to further the development of drugs nurt...

InterMed Discovery: The World's Largest Natural Product Library

In this interview Fintan Walton talks to Mr Erik Metz, Head of Business Development at InterMed Discovery - a Natural Product lead discovery company from Dortmund, Germany. Erik Metz explains how Inte...

Drug Discovery Outsourcing Global Market Forecast To 2025 [Report Updated: 14092017] Prices from USD $7200

Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biolog...

C4X Discovery Holdings (C4XD) - Termination of coverage

Edison Investment Research - Pharmaceutical & healthcare - C4X Discovery Holdings: Edison Investment Research is terminating coverage on C4X Discovery Holdings (C4XD). Please note you should no longer...

Opportunities and challenges in phenotypic drug discovery: an industry perspective

There has been a resurgence in interest in phenotypic drug discovery (PDD) approaches in recent years based on their potential to address the incompletely understood complexity of diseases and their p...

Takeda accesses HemoShear's REVEAL-Tx platform for NASH drug discovery

HemoShear Therapeutics LLC and Takeda Pharmaceutical Co. Ltd. will work together on the discovery and development of new treatments for nonalcoholic steatohepatitis (NASH) and other liver diseases.

PubMed Articles [1067 Associated PubMed Articles listed on BioPortfolio]

The Current State of Peptide Drug Discovery: Back to the Future?

Over the last decade, peptide drug discovery has experienced a revival of interest and scientific momentum, as the pharmaceutical industry has come to appreciate the role that peptide therapeutics can...

Allosteric Tuning of Caspase-7: a Fragment-Based Drug Discovery Approach.

The caspase family of cysteine proteases are highly sought after drug targets due to their essential roles in apoptosis, proliferation and inflammation pathways. High throughput screening efforts to d...

Commentary: Why Pharmaceutical Scientists in Early Drug Discovery Are Critical for Influencing the Design and Selection of Optimal Drug Candidates.

This commentary reflects the collective view of pharmaceutical scientists from four different organizations with extensive experience in the field of drug discovery support. Herein, engaging discussio...

How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.

Since 2011, phenotypic screening has been a trend in the pharmaceutical industry as well as in academia. This renaissance was triggered by analyses that suggested that phenotypic screening is a superi...

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

The need for novel approaches to cardiovascular drug development served as the impetus to convene an open meeting of experts from the pharmaceutical industry and academia to assess the challenges and ...

Clinical Trials [553 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Companies [2553 Associated Companies listed on BioPortfolio]

The Institutes for Pharmaceutical Discovery, LLC

The Institutes for Pharmaceutical Discovery, LLC (IPD) is a privately held company founded by James M. Nolan, President and CEO, and Gordon Polley, Chairman.IPD is managed by a cadre of experienced ph...

Institute for Diabetes Discovery

The Institute for Diabetes Discovery, LLC, (IDD) is the largest privately-held biopharmaceutical company in the United States dedicated to the research and discovery of novel drugs and therapeutics fo...

Pyxis Discovery

Pyxis Discovery offers chemistry-based drug discovery services to the global pharmaceutical industry and develops products and services on the basis of computational chemistry. The activities of Pyxis...

Tularik Incorporated

We have developed a drug discovery and development infrastructure that we believe positions us to become a leading pharmaceutical company. Our drug discovery and development expertise includes molecul...

Affymax

Affymax, Inc. is a drug discovery powerhouse uniquely positioned to leverage over a decade of pharmaceutical drug discovery experience. As an industry pioneer with a five-year history working inside G...

More Information about "The Institutes for Pharmaceutical Discovery, LLC" on BioPortfolio

We have published hundreds of The Institutes for Pharmaceutical Discovery, LLC news stories on BioPortfolio along with dozens of The Institutes for Pharmaceutical Discovery, LLC Clinical Trials and PubMed Articles about The Institutes for Pharmaceutical Discovery, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Institutes for Pharmaceutical Discovery, LLC Companies in our database. You can also find out about relevant The Institutes for Pharmaceutical Discovery, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record